Viewing Study NCT05994157


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-07 @ 5:25 AM
Study NCT ID: NCT05994157
Status: RECRUITING
Last Update Posted: 2025-01-29
First Post: 2023-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor: Y-mAbs Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module